|
Volumn 104, Issue 25, 2001, Pages
|
Texas oncologist head of National Cancer Institute.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADMINISTRATIVE PERSONNEL;
ARTICLE;
HEALTH CARE ORGANIZATION;
HUMAN;
ONCOLOGY;
UNITED STATES;
DOSE RESPONSE;
FOOD AND DRUG ADMINISTRATION;
IATROGENIC DISEASE;
LONG QT SYNDROME;
POSTMARKETING SURVEILLANCE;
TORSADE DES POINTES;
ANIMAL;
GENETICS;
HEART ARRHYTHMIA;
MOUSE;
MUTATION;
SUDDEN DEATH;
ADMINISTRATIVE PERSONNEL;
HUMAN;
MEDICAL ONCOLOGY;
NATIONAL INSTITUTES OF HEALTH (U.S.);
TEXAS;
UNITED STATES;
ANTIPSYCHOTIC AGENTS, BUTYROPHENONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DROPERIDOL;
LONG QT SYNDROME;
PRODUCT SURVEILLANCE, POSTMARKETING;
TORSADES DE POINTES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
ANIMAL;
ARRHYTHMIA;
CALCIUM-BINDING PROTEINS;
DEATH, SUDDEN;
MICE;
MUTATION;
DROPERIDOL;
NEUROLEPTIC AGENT;
CALCIUM BINDING PROTEIN;
CALCIUM BINDING PROTEINS;
KV CHANNEL INTERACTING PROTEIN 2;
KV CHANNEL-INTERACTING PROTEIN 2;
|
EID: 17544389464
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|